ES2011577A6 - Un procedimiento para preparar una composicion antiviral o antibacteriana mediante enzimas. - Google Patents

Un procedimiento para preparar una composicion antiviral o antibacteriana mediante enzimas.

Info

Publication number
ES2011577A6
ES2011577A6 ES8901637A ES8901637A ES2011577A6 ES 2011577 A6 ES2011577 A6 ES 2011577A6 ES 8901637 A ES8901637 A ES 8901637A ES 8901637 A ES8901637 A ES 8901637A ES 2011577 A6 ES2011577 A6 ES 2011577A6
Authority
ES
Spain
Prior art keywords
dimer
antiviral
ribonuclease
lysozyme
emanufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8901637A
Other languages
English (en)
Inventor
Witold Kicka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nika Health Products Ltd
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of ES2011577A6 publication Critical patent/ES2011577A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION ANTIVIRAL O ANTIBACTERIANA MEDIANTE ENZIMAS, QUE COMPRENDE DIMERIZAR UNA ENZIMA SELECCIONADA DEL GRUPO QUE CONSISTE EN LISOZIMA Y RIBUNUCLEASA, Y MEZCLAR EL DIMERO OBTENIDO CON UN VEHICULO FARMACEUTICAMENTE ACEPTABLE, LLEVANDOSE A CABO DICHA MEZCLA A UNA TEMPERATURA DE 20 A 60GC. LA COMPOSICION OBTENIDA ES UTIL PARA TRATAR INFECCIONES VIRALES O ANTIBACTERIANAS TALES COMO HERPES, HERIDAS INFECCIOSAS, INFECCIONES VAGINALES, OTITIS O SIMILARES.
ES8901637A 1988-05-26 1989-05-16 Un procedimiento para preparar una composicion antiviral o antibacteriana mediante enzimas. Expired - Fee Related ES2011577A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
ES2011577A6 true ES2011577A6 (es) 1990-01-16

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8901637A Expired - Fee Related ES2011577A6 (es) 1988-05-26 1989-05-16 Un procedimiento para preparar una composicion antiviral o antibacteriana mediante enzimas.

Country Status (23)

Country Link
US (3) US5200182A (es)
EP (1) EP0380484B1 (es)
JP (1) JPH0649659B2 (es)
AT (1) ATE93143T1 (es)
AU (1) AU624331B2 (es)
BG (1) BG60544B1 (es)
CA (1) CA1335425C (es)
CS (1) CS277030B6 (es)
DK (1) DK173078B1 (es)
ES (1) ES2011577A6 (es)
FI (1) FI900412A0 (es)
HK (1) HK42394A (es)
HU (1) HU204710B (es)
IL (1) IL90092A (es)
LV (1) LV10054B (es)
MA (1) MA21560A1 (es)
MW (1) MW390A1 (es)
OA (1) OA09785A (es)
PH (1) PH26284A (es)
RU (1) RU2092183C1 (es)
WO (1) WO1989011294A1 (es)
YU (1) YU109289A (es)
ZA (1) ZA893382B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2092183C1 (ru) * 1988-05-26 1997-10-10 Ника Хелт Продактс Лимитед (Лихтенштейн) Антивирусный или антибактериальный состав и способ его употребления
ATE136056T1 (de) * 1990-01-08 1996-04-15 Nika Health Products Ltd Verfahren zur herstellung von ribonuklease- dimeren
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
WO2005115477A2 (en) 2004-04-13 2005-12-08 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
EP2044097A4 (en) * 2006-06-23 2010-10-06 Quintessence Biosciences Inc MODIFIED RIBONUCLEASES
WO2008010991A2 (en) 2006-07-17 2008-01-24 Quintessence Biosciences, Inc. Methods and compositions for the treatment of cancer
US7846430B2 (en) * 2007-03-02 2010-12-07 Stefano Ferrari Composition and method for treating bovine papilloma virus in equine
US20100317677A1 (en) * 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
JP2010540681A (ja) * 2007-10-08 2010-12-24 クインテッセンス バイオサイエンシズ，インコーポレーテッド リボヌクレアーゼに基づく治療のための組成物及び方法
JP2012504423A (ja) 2008-10-01 2012-02-23 クインテッセンス バイオサイエンシズ，インコーポレーテッド 治療用リボヌクレアーゼ
WO2010099182A1 (en) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Activated creatinine and precursors as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
PL2457576T3 (pl) 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
WO2013180585A1 (en) 2012-05-29 2013-12-05 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
WO2014152678A1 (en) 2013-03-15 2014-09-25 University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
WO2015125961A1 (ja) 2014-02-21 2015-08-27 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
KR20170038829A (ko) * 2014-07-31 2017-04-07 큐피가부시키가이샤 함수 유동상 조성물 및 그 제조 방법, 그리고 리소자임 가공품 및/또는 그 염 그리고 그 제조 방법
MX2017003465A (es) 2014-09-17 2017-06-19 Spogen Biotech Inc Proteinas de fusion, bacterias recombinantes y metodos de uso de las bacterias recombinantes.
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
KR102470362B1 (ko) 2016-12-28 2022-11-25 디아이씨 가부시끼가이샤 분산체 및 그것을 사용한 잉크젯용 잉크 조성물, 광변환층, 및 액정 표시 소자
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (es) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
CA1263378A (en) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
RU2092183C1 (ru) * 1988-05-26 1997-10-10 Ника Хелт Продактс Лимитед (Лихтенштейн) Антивирусный или антибактериальный состав и способ его употребления

Also Published As

Publication number Publication date
FI900412A0 (fi) 1990-01-25
DK16890A (da) 1990-01-22
HK42394A (en) 1994-05-13
HUT54060A (en) 1991-01-28
BG60544B1 (en) 1995-08-28
JPH0649659B2 (ja) 1994-06-29
MW390A1 (en) 1990-11-14
YU109289A (en) 1991-08-31
AU1940888A (en) 1989-12-12
LV10054A (lv) 1994-05-10
DK173078B1 (da) 1999-12-20
EP0380484B1 (en) 1993-08-18
OA09785A (en) 1994-04-15
HU204710B (en) 1992-02-28
AU624331B2 (en) 1992-06-11
CS318089A3 (en) 1992-05-13
ATE93143T1 (de) 1993-09-15
EP0380484A1 (en) 1990-08-08
RU2092183C1 (ru) 1997-10-10
LV10054B (en) 1995-02-20
US5466449A (en) 1995-11-14
WO1989011294A1 (en) 1989-11-30
ZA893382B (en) 1991-01-30
CA1335425C (en) 1995-05-02
PH26284A (en) 1992-04-10
MA21560A1 (fr) 1989-12-31
DK16890D0 (da) 1990-01-22
JPH03504121A (ja) 1991-09-12
HU883981D0 (en) 1990-12-28
CS277030B6 (en) 1992-11-18
IL90092A (en) 1995-03-30
US6099835A (en) 2000-08-08
US5200182A (en) 1993-04-06

Similar Documents

Publication Publication Date Title
ES2011577A6 (es) Un procedimiento para preparar una composicion antiviral o antibacteriana mediante enzimas.
CA2145826A1 (en) Lipopeptide derivatives, a process for their preparation and their use
EP0271581A4 (en) NOVEL DC-88A AND DC-89A1 COMPOUNDS, AND PROCESS FOR THEIR PREPARATION.
AU4684993A (en) Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
CA2067381A1 (en) Treatment of hiv infections and compounds useful therein
HUT41821A (en) Process for preparing amide derivatives of teicoplanine compounds
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
ZA90245B (en) Treatment of diseases associated with hiv infections
AU7370491A (en) 2,8-dioxabicyclo(3,2,1)octane derivatives,their production from cultures of MF 5447 and MF 5466 and their use as anti hyper cholesterolemics
AU4025689A (en) Method of using plant nucleoside derivatives for treatment of viral infections
CA2137395A1 (en) 9a-N-(N'-Carbamoyl) and 9a-N-(N' - Thiocarbamoyl) Derivatives of 9-Deoxo-9a-AZA-9a-Homoerythromycin A
HRP930014B1 (es)
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
IL82937A0 (en) Pyrrolinylacetamide,processes for the preparation thereof and the use thereof
IE871731L (en) Antibiotic from strep. lydicus
RU94019991A (ru) Антибиотическая композиция
ES2018726A6 (es) Procedimiento para preparar derivdos de mitomicina.
IL69093A (en) Method for preparing 20-deoxo-23-de(mycinosyloxy)tylosin antibiotics,the novel 20-deoxo-23-de(mycinoslyloxy)tylosin derivatives,their use as intermediates and pharmaceutical compositions containing them
CA2024497A1 (en) Chemical derivatives of antibiotics ll-f19020 alpha and beta
AU7536387A (en) Furnace for the high temperature treatment of plastic or hardened products
AU7379587A (en) Pharmaceutical formulation for the treatment of bacterial infections
AU6600190A (en) Therapeutic compositions; methods for treatment of hiv infections
AU7720391A (en) C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
AU8668091A (en) Air-inlet pipe, preferably for the driving cabins of agricultural tractors
AU601474B2 (en) A new macrolide antibiotic, a microbiological process for its preparation, and its use as a medicinal agent

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2009-05-16

FD1A Patent lapsed

Effective date: 20100315